These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28189289)

  • 1. Continuous quality improvement in substance abuse treatment facilities: How much does it cost?
    Hunt P; Hunter SB; Levan D
    J Subst Abuse Treat; 2017 Jun; 77():133-140. PubMed ID: 28189289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Employing continuous quality improvement in community-based substance abuse programs.
    Chinman M; Hunter SB; Ebener P
    Int J Health Care Qual Assur; 2012; 25(7):604-17. PubMed ID: 23276056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous quality improvement (CQI) in addiction treatment settings: design and intervention protocol of a group randomized pilot study.
    Hunter SB; Ober AJ; Paddock SM; Hunt PE; Levan D
    Addict Sci Clin Pract; 2014 Jan; 9(1):4. PubMed ID: 24467770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Service-level costing of drug abuse treatment.
    Anderson DW; Bowland BJ; Cartwright WS; Bassin G
    J Subst Abuse Treat; 1998; 15(3):201-11. PubMed ID: 9633032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
    Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
    Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing evidence-based continuous quality improvement strategies in an urban Aboriginal Community Controlled Health Service in South East Queensland: a best practice implementation pilot.
    Hogg S; Roe Y; Mills R
    JBI Database System Rev Implement Rep; 2017 Jan; 15(1):178-187. PubMed ID: 28085734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Building capacity for continuous quality improvement (CQI): A pilot study.
    Hunter SB; Rutter CM; Ober AJ; Booth MS
    J Subst Abuse Treat; 2017 Oct; 81():44-52. PubMed ID: 28847454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.
    Mojtabai R; Zivin JG
    Health Serv Res; 2003 Feb; 38(1 Pt 1):233-59. PubMed ID: 12650390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating primary medical care with addiction treatment: a randomized controlled trial.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Lu Y
    JAMA; 2001 Oct; 286(14):1715-23. PubMed ID: 11594896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Quality Improvement in the Substance Abuse and Mental Health Services Administration's Technology Transfer Center Network: A Process Evaluation.
    Agley J; Gassman R; Reho K; Roberts J; Heil SKR; Castillo G; Golzarri-Arroyo L
    Eval Health Prof; 2024 Jun; 47(2):154-166. PubMed ID: 38790107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance abuse treatment: outcomes of managed care techniques.
    Chung R; Filstead WJ
    Behav Healthc Tomorrow; 1995; 4(6):78-9, 58. PubMed ID: 10172617
    [No Abstract]   [Full Text] [Related]  

  • 15. Adapting Washington Circle performance measures for public sector substance abuse treatment systems.
    Garnick DW; Lee MT; Horgan CM; Acevedo A;
    J Subst Abuse Treat; 2009 Apr; 36(3):265-77. PubMed ID: 18722075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous quality improvement as a tool to implement evidence-informed problem solving: experiences from the district and health facility level in Uganda.
    Tibeihaho H; Nkolo C; Onzima RA; Ayebare F; Henriksson DK
    BMC Health Serv Res; 2021 Jan; 21(1):83. PubMed ID: 33482799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP).
    Salomé HJ; French MT; Miller M; McLellan AT
    Drug Alcohol Depend; 2003 Aug; 71(2):195-206. PubMed ID: 12927658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managed care and outpatient substance abuse treatment intensity.
    Lemak CH; Alexander JA
    J Behav Health Serv Res; 2001 Feb; 28(1):12-29. PubMed ID: 11329996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of continuous quality improvement in Aboriginal and Torres Strait islander primary health care in Australia.
    Sibthorpe B; Gardner K; Chan M; Dowden M; Sargent G; McAullay D
    J Health Organ Manag; 2018 Jun; 32(4):545-571. PubMed ID: 29969347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of Screening, Brief Intervention, and Referral to Treatment in Health Care Settings.
    Barbosa C; Cowell AJ; Landwehr J; Dowd W; Bray JW
    J Subst Abuse Treat; 2016 Jan; 60():54-61. PubMed ID: 26160162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.